ALC News and Press, Alcon Inc. From 10/14/21

Alcon associates across 43 global sites take the Steps for Sight challenge, raising funds to support organizations improving access to quality eye care Alcon Geneva associates will dedicate the day to learning more about the importance of eye health, including onsite vision ...

With 62 recent IPOs becoming part of The Russell 2000 small-cap index following its Q3 recalibrations, we highlight the healthcare stocks among the new entrants. The below discussion is a follow-up to the previous article on newly IPO’d healthcare constituents in the Index. R...

After 62 recent IPOs made their way to The Russell 2000 small-cap index following the Q3 recalibrations implemented by its index provider, we showcase the healthcare stocks among the new entrants. The below discussion on newly IPO’ed healthcare constituents in the Index follo...

Award recognizes Alcon’s ForeSight enterprise data and analytics platform Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has been recognized as a recipient of the FutureEdge 50 Award from International Data Group ...

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Total return for Harding Loevner International Equity Fund net of fees was 5.43% vs. MSCI All Country World ex-US ...

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

The medical devices industry has been performing remarkably well over the past year. And we think this trend will likely continue, driven by rising demand for non-emergency medical procedures and tech integration. Thus, quality medical device stocks ResMed Inc. (RMD), Alcon Inc. (ALC), Terumo...

Since the company's creation, Alcon has been a leading innovator and created a powerful moat by continuously launching new products for the eye-care industry. The recent developments announced during the latest earnings call are part of a multi-year plan to increase revenue by over 30...

Wedgewood Partners’ 13F portfolio value increased ~6% from $650M to ~$690M this quarter. They increased Booking Holdings while reducing Alcon and Bristol Myers Squibb. Their top five positions are at 38% of the overall portfolio. For further details see: Tracking ...

Of your five senses, eye sight ranks up there as most important, and essential. Unfortunately, for some of us, we don’t have the best vision. In fact, some of us deal with what’s known as Aniseikonia, or as noted by Clinical and Experimental Optometry “is a difference i...